Modulation of the immune response using dendritic cell-derived exosomes

Methods in Molecular Biology

Volumn 380, Issue , 2007, Pages 443-455

  Bianco, Nicole R ^a   Kim, Seon Hee ^a   Morelli, Adrian E ^a   Robbins, Paul D ^a  

^a NONE

Author keywords

Autoimmune disease; Collageninduced arthritis; Delayed type hypersensitivity; Dendritic cells; Exosomes; Rheumatoid arthritis

Indexed keywords

ANIMAL; ARTHRITIS; ARTICLE; CELL MEMBRANE; CYTOLOGY; DENDRITIC CELL; EXOCYTOSIS; IMMUNOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL MEMBRANE; DENDRITIC CELLS; EXOCYTOSIS;

MURINAE;

EID: 36549086680     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1385/1-59745-395-1:443     Document Type: Article

References (22)

1. Pan, B. T and Johnstone, R. M. (1983) Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33, 967-978.
2. Denzer, K., Kleijmeer, M. J., Heijnen, H. F., Stoorvogel, W., and Geuze, H. J. (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 113, 3365-3374.
3. Thery, C., Zitvogel, L., and Amigorena, S. (2002) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579.
4. Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., and Turbide, C. (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262, 9412-9420.
5. Zitvogel, L., Regnault, A., Lozier, A., et al. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4, 594-600.
6. Chaput, N., Schartz, N. E., Andre, F., et al. (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172, 2137-2146.
7. Morse, M. A., Garst, J., Osada, J., et al. (2005) A phase I study of exosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3, 9.
8. Escudier, B., Dorval, T., Chaput, N., et al. (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med. 3, 10.
9. Altieri, S. L., Khan, A. N., and Tomasi, T. B. (2004) Exosomes from plasmacytoma cells as a tumor vaccine. J. Immunother. 27, 282-288.
10. Aline, F., Bout, D., Amigorena, S., Roingeard, P., and Dimier-Poisson, I. (2004) Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T gondii infection. Infect. Immun. 72, 4127-4137.
11. Karlsson, M., Lundin, S., Dahlgren, U., Kahu, H., Pettersson, I., and Telemo, E. (2001) "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31, 2892-2900.
12. Peche, H., Heslan, M., Usal, C., Amigorena, S., and Cuturi, M. C. (2003) Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76, 1503-1510.
13. Andreola, G., Rivoltini, L., Castelli, C., et al. (2002) Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195, 1303-1316.
14. Martinez-Lorenzo, M. J., Anel, A., Gamen, S., et al. (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163, 1274-1281.
15. Abrahams, V. M., Straszewski, S. L., Kamsteeg, M., et al. (2003) Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 63, 5573-5581.
16. Abusamra, A. J., Zhong, Z., Zheng, X., et al. (2005) Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol. Dis. 35, 169-173.
17. Frangsmyr, L., Baranov, V., Nagaeva, O., Stendahl, U., Kjellberg, L., and Mincheva-Nilsson, L. (2005) Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod. 11, 35-41.
18. Kim, S. H., Lechman, E. R., Bianco, N., et al. (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol. 174, 6440-6448.
19. Hee Kim, S., Bianco, N., Menon, R., et al. (2005) Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol. Ther. 13, 289-300.
20. Son, Y. I., Egawa, S., Tatsumi, T., Redlinger, R. E., Jr., Kalinski, P., and Kanto, T (2002) A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods 262, 145-157.
21. Thery, C., Boussac, M., Veron, P., et al. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 166, 7309-7318.
22. Wubbolts, R., Leckie, R. S., Veenhuizen, P. T., et al. (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278, 10,963-10,972.